Rotavirus Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-03-27
Clinical Trial Update: Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine [Phase 2]
A Phase 2 study evaluating a birth dose of GlaxoSmithKline's 251154 rotavirus vaccine has been withdrawn.